Schedule 13D ownership disclosure
EVELO BIOSCIENCES INC
Security class unavailable · CUSIP: 299734103
Event date: 2022-05-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-165305
- Form type
- SC 13D
- Filer
- Evelo Biosciences, Inc.
- CIK
- CIK 1694665
- Filed
- Jun 01, 2022
- Reporting period
- May 27, 2022
- Description
- Schedule 13D beneficial ownership